GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » EV-to-FCF

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) EV-to-FCF : 24.11 (As of Apr. 16, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Jiangsu Kanion Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jiangsu Kanion Pharmaceutical Co's Enterprise Value is ¥5,444 Mil. Jiangsu Kanion Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ¥226 Mil. Therefore, Jiangsu Kanion Pharmaceutical Co's EV-to-FCF for today is 24.11.

The historical rank and industry rank for Jiangsu Kanion Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SHSE:600557' s EV-to-FCF Range Over the Past 10 Years
Min: -436.94   Med: 17.92   Max: 1054.81
Current: 23.86

During the past 13 years, the highest EV-to-FCF of Jiangsu Kanion Pharmaceutical Co was 1054.81. The lowest was -436.94. And the median was 17.92.

SHSE:600557's EV-to-FCF is ranked worse than
51.83% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs SHSE:600557: 23.86

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-16), Jiangsu Kanion Pharmaceutical Co's stock price is ¥12.85. Jiangsu Kanion Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.670. Therefore, Jiangsu Kanion Pharmaceutical Co's PE Ratio (TTM) for today is 19.18.


Jiangsu Kanion Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Jiangsu Kanion Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Kanion Pharmaceutical Co EV-to-FCF Chart

Jiangsu Kanion Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.56 8.89 11.94 14.58 26.04

Jiangsu Kanion Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.58 11.59 15.72 16.57 26.04

Competitive Comparison of Jiangsu Kanion Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Kanion Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Kanion Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Kanion Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Jiangsu Kanion Pharmaceutical Co's EV-to-FCF falls into.


;
;

Jiangsu Kanion Pharmaceutical Co EV-to-FCF Calculation

Jiangsu Kanion Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5443.826/225.804
=24.11

Jiangsu Kanion Pharmaceutical Co's current Enterprise Value is ¥5,444 Mil.
Jiangsu Kanion Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥226 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Kanion Pharmaceutical Co  (SHSE:600557) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jiangsu Kanion Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12.85/0.670
=19.18

Jiangsu Kanion Pharmaceutical Co's share price for today is ¥12.85.
Jiangsu Kanion Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.670.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Jiangsu Kanion Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Jiangsu Kanion Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Kanion Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001
Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.
Executives
Pan Yu Director
Xu Dian Hong Director
Wang Chuan Lei Director
Yang Yong Chun Director
Liu Quan Director
Wang Zhen Zhong Director
Wu Yun Director
Gao Hai Xin Director
Xiao Wei Director
Wan Yan Huan senior management
Xia Yue Director
Yang Yin Director

Jiangsu Kanion Pharmaceutical Co Headlines

No Headlines